Evonik Supports Science Education At Temple University Ambler
Grant From Global Innovation Leader Marks Company's New Corporate Identity
HORSHAM, Pa., December 4, 2007 – Evonik Industries, whose chemical operations were formally known as Degussa, today presented Temple University Ambler with a $500 community grant to support the District's science education programs.
Greg Bialy, president and CEO of Evonik’s RohMax USA, said the company made the donation to introduce its new identity.
"We're proud of what we do here in Horsham and we are proud of the chemical industry," Bialy said. "Chemistry is a cornerstone of our society. Without it, many of the products, conveniences and medicines to which we've become accustomed would not exist."
Linda Lowe, Director of Development and Alumni Affairs at Temple University Ambler said that the donation from Evonik Degussa is very much appreciated. “We are always grateful for all gifts directed towards financial assistance for students,” she added. “Temple Ambler values the generosity and partnership with companies like Evonik Degussa Corporation.”
Bialy added that the $500 grant is Evonik’s way of celebrating with its neighbors in Horsham but is also a continuation of the company-wide commitment to education.
“By supporting our educational institutions,” Bialy said, “we are investing in the development of new scientific discoveries, future research and development researchers, and global economic advancement.”
Company information
Evonik Industries AG is the creative industrial group which operates in three highly profitable, promising business areas: Chemicals, Energy and Real Estate. Evonik is a global leader in specialty chemicals, an expert in power generation from hard coal and renewable energies, and one of the largest private residential real estate companies in Germany. Our strengths are creativity, specialization, continuous self-renewal, and reliability.
Evonik Industries is active in over 100 countries around the world. In fiscal 2006 around 43,000 employees generated sales of €14.8 billion and operating profit (EBIT) of over €1.2 billion. Evonik plans to enter the capital market in the first half of 2008.
Disclaimer
In so far as forecasts or expectations are expressed in this press release and where our forward-looking statements concern the future, these forecasts, expectations and statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Evonik Industries AG assumes no obligation to update the forecasts, expectations or statements contained in this release.
For more information, contact:
Mike Sheridan
Evonik Degussa Corporation
Tel: 973-541-8812
e-mail: mike.sheridan@degussa.com